NYSE · CIK 0001821825
OGN Organon & Co.
Insider trading from SEC Form 4. Last filing Feb 24, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at Organon & Co., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
3 trades in OGN disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Kevin Hern House · R-OK | Sale | OGN Organon & Co. Common Stock | $1,001 to $15k | Aug 5, 2026 | 7 days after the trade |
| Kevin Hern House · R-OK | Sale | OGN Organon & Co. Common Stock | $1,001 to $15k | Aug 5, 2026 | 5 days after the trade |
| Gary C. Peters Senate · D-MI | Sale | OGN Organon & Co. | $1,001 to $15k | Jul 10, 2025 | 137 days after the trade |
Transactions
The last 11 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | Kevin Ali Chief Executive Officer | AGrant or award Common Stock | +84,222 | $0.00 | $0 | 229,110 | Feb 24, 2025 |
| Feb 20, 2025 | Aaron Falcione Chief Human Resources Officer | AGrant or award Common Stock | +14,037 | $0.00 | $0 | 46,696 | Feb 24, 2025 |
| Feb 20, 2025 | Kevin Ali Chief Executive Officer | FTax withholding Common Stock | -46,575 | $14.92 | $695k | 182,535 | Feb 24, 2025 |
| Feb 20, 2025 | Aaron Falcione Chief Human Resources Officer | FTax withholding Common Stock | -5,154 | $14.92 | $77k | 41,542 | Feb 24, 2025 |
| Feb 20, 2025 | Kevin Ali Chief Executive Officer | AGrant or award Common Stock | +15,423 | $0.00 | $0 | 197,958 | Feb 24, 2025 |
| Feb 20, 2025 | Aaron Falcione Chief Human Resources Officer | AGrant or award Common Stock | +2,571 | $0.00 | $0 | 44,113 | Feb 24, 2025 |
| Feb 20, 2025 | Kevin Ali Chief Executive Officer | FTax withholding Common Stock | -8,529 | $15.29 | $130k | 199,919 | Feb 24, 2025 |
| Feb 20, 2025 | Aaron Falcione Chief Human Resources Officer | FTax withholding Common Stock | -881 | $15.29 | $13k | 45,981 | Feb 24, 2025 |
| Nov 7, 2024 | Ferreira Juan Camilo Arjona Head of R&D & CMO | MOption exercise Common Stock | +6,446 | $0.00 | $0 | 13,987 | Nov 8, 2024 |
| Nov 7, 2024 | Ferreira Juan Camilo Arjona Head of R&D & CMO | FTax withholding Common Stock | -2,300 | $15.80 | $36k | 11,687 | Nov 8, 2024 |
| Nov 7, 2024 | Ferreira Juan Camilo Arjona Head of R&D & CMO | MOption exercise Restricted Stock Unitsderivative | -6,446 | $0.00 | $0 | 12,893 | Nov 8, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Kevin AliChief Executive Officer
- Ferreira Juan Camilo ArjonaHead of R&D & CMO
- Aaron FalcioneChief Human Resources Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.